Consistently, oral administration of BC was found to significantly decrease ER levels in patients with sensitive PRLomas.38 The observations support that AMPK activation inhibits of ERα and ERβ expression in PRLomas. The gene discussed is ESR2; the disease is prolactin-producing pituitary gland adenoma.